Ultrasound Probe Pressure on the Intratendon Doppler Signal in Patellar Tendinopathy

February 7, 2023 updated by: SERGIO MONTERO NAVARRO, Cardenal Herrera University

Evaluation of the Influence of Ultrasound Probe Pressure on the Intratendon Doppler Signal in Patellar Tendinopathy

In the sports field, patellar tendinopathy is, as a pathology, one of the main concerns for athletes, both because of its incidence and because of the difficulty involved in their recovery. At the ultrasound level, tendinopathies can be divided, depending on the presence or absence of an intratendon Doppler signal, into hypervascular or hypovascular tendinopathy. Its classification is, today and clinically speaking, merely qualitative through the observation of the explorer. The ultrasound evaluation is carried out through a probe that is placed on the patient's skin, the procedure to be followed to obtain a vascular image is merely operator-dependent, that is, the position of the probe, the pressure exerted on the skin or even ultrasound optimization parameters can drastically modify the results.

Due to high pressure on the probe, the intratendon Doppler signal may be diminished in the quantitative variables of area, number of signals, pixel intensity, perimeter, solidity, perfusion index, circularity, major and minor diameter.

From a certain pressure on the probe, the intratendon Doppler signal can be drastically altered.

This study will try to evaluate the influence of the pressure exerted by the examiner with the probe on the quantitative variables of the intratendon Doppler signal in patellar tendinopathy.

To carry out the study, a single group with patellar tendinopathy will be established. Ultrasound evaluations with Doppler mode will be performed on the tendon using different probe pressures, monitoring the applied force and recording the images obtained for later analysis.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alicante
      • Elche, Alicante, Spain, 03204
        • CEU Cardenal Herrera University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Acceptance of participation in the study.
  • Diagnosis of patellar tendinopathy with the presence of an intratendon Doppler signal.
  • Subjects between the ages of 18 and 65.

Exclusion Criteria:

  • Present some type of surgical intervention in the region to be explored that could alter in some way the ultrasound evaluation.
  • Refer vascular pathology or the intake of medication that may alter blood flow or density.
  • Having been treated with sclerosing techniques that can alter the perfusion or vascular resistance of the tendon tissue.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: intratendon vascularization
Intratendon vascularization will be quantified using a proprietary methodology using ImageJ 1.47v image analysis software, determining the different variables related to the Doppler signal within an intratendon region of interest.
Ultrasonic exploration by power-Doppler of the intratratendon vascularization, making longitudinal cuts of the patellar tendon and with previously pre-established Doppler optimization parameters for all patients. The optimization parameters of the power-Doppler signal will be set at a Doppler frequency of 6.7 MHz, pulse repetition frequency (PRF) of 0.7 kHz. The lowest wall filter and a standardized gain just below the level that produces random noise will be applied. This examination will be repeated several times with different probe pressures, which will be quantitatively adjusted through the force sensor and maintained with the articulated arm. A 4-second static video will be recorded of the longitudinal section that presents a higher Doppler signal in each of the scans at different probe pressures.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of signals (n)
Time Frame: during intervention
number of intratendon doppler signals (unit)
during intervention
Average pixel intensity (0-255 Units on a scale)
Time Frame: during intervention
average pixel color intensity (0-255 Units on a scale)
during intervention
Area (mm^2)
Time Frame: during intervention
intratendon Doppler signal area (mm^2)
during intervention
Perimeter (mm)
Time Frame: during intervention
perimeter of the intratendon Doopler signal (mm)
during intervention
major diameter (mm)
Time Frame: during intervention
major diameter of the intratendon Doppler signal (mm)
during intervention
minor diameter (mm)
Time Frame: during intervention
minor diameter of the intratendon Doppler signal (mm)
during intervention
Circularity
Time Frame: during intervention
measure of roundness or circularity, area-to perimeter ratio. (0-1 Units on a scale)
during intervention
Solidity
Time Frame: during intervention
measures the density of an object (0-1 Units on a scale)
during intervention
Resistance index
Time Frame: during intervention
resistance index of intratendon Doppler signals (0-1 Units on a scale)
during intervention
Force
Time Frame: during intervention
force applied by the probe on the knee during the scan (N)
during intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age (years)
Time Frame: Post-intervention
subject's age (years)
Post-intervention
Sex (female or male)
Time Frame: post-intervention
subject's sex (female or male)
post-intervention
Time of evolution (months)
Time Frame: months
time since the patient had the first symptoms (months)
months
Dominance
Time Frame: post-intervention
Dominant leg (right-left)
post-intervention
Pain location
Time Frame: Immediately pre-intervention
Location of pain in the patellar tendon (lower pole of the patella-body of the tendon-insertion in the anterior tuberosity of the tibia)
Immediately pre-intervention
Victorian Institute of Sport Assessment-Patella (VISA-P)
Time Frame: Immediately pre-intervention
Knee pain and function rating scale (0-100 Units on a scale). The maximum score possible is 100 points and represents an asymptomatic athlete who can fully engage in sports. The theoretical minimum is 0 point. The test is carried out just before the intervention to relate the results of the Doppler quantification with the severity of the pain.
Immediately pre-intervention
hours of training (hours)
Time Frame: Immediately pre-intervention
Current training hours per week (hours). This question is asked just before the intervention in order to relate the results of the Doppler quantification with the hours of training performed
Immediately pre-intervention
Time without training (months)
Time Frame: Immediately pre-intervention
time without training (months). This question is asked just before the intervention.
Immediately pre-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 18, 2020

Primary Completion (ACTUAL)

August 30, 2022

Study Completion (ACTUAL)

February 7, 2023

Study Registration Dates

First Submitted

December 9, 2020

First Submitted That Met QC Criteria

December 22, 2020

First Posted (ACTUAL)

December 23, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 8, 2023

Last Update Submitted That Met QC Criteria

February 7, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • CEI20/073

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patellar Tendinitis

Clinical Trials on Intratendon vascularization

Subscribe